BIOCRYST PHARMACEUTICALS, INC. Restructuring Reserve
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Restructuring Reserve of $64.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-08-05
- 2026-06-30: Restructuring Reserve $64.00K.
- 2026-03-31: Restructuring Reserve $596.00K.
- 2025-12-31: Restructuring Reserve $5.48M.
- 2024-12-31: Restructuring Reserve $0.00.
| Period end | Restructuring Reserve |
|---|---|
| 2026-06-30 | $64.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $596.00K 10-Q · filed 2026-08-05 |
| 2025-12-31 | $5.48M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-09-30 | $6.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $297.00K 10-Q · filed 2024-11-05 |
| 2024-03-31 | $1.48M 10-Q · filed 2024-11-05 |
| 2023-12-31 | $3.38M 10-K · filed 2026-02-26 |
| 2013-09-30 | $158.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $249.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $387.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.70M 10-K · filed 2015-03-02 |
| 2010-12-31 | $158.00K 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |